Company news: InTouch Solutions, MedCityNews and Lippincott

Share this article:
Healthcare agency and platform developer InTouch Solutions partnered with marketing firm MD Mindset to deliver a joint set of services. Wendy Blackburn, InTouch EVP, told MM&M the collaboration is still in its defining stages, but that the relationship will allow the two companies to offer their complementary skill sets to clients in tandem, or to introduce each other's capabilities as client needs arise. Services on tap include InTouch's Allora platform, which the agency uses to build apps, and MD Mindset's usage metrics that can be used to assess what makes a tablet presentation effective on sales calls. “You can't take it for granted that people are building iPad apps the right way...it's far too easy to take a viz aide and throw a PDF onto an iPad," she said. "It is a lot less about what the pharma company wants to provide in terms of messaging...it's much more about what the doctor wants to see, and that's where we can really make a difference.”

Content Marketing Institute and MedCityNews.com are holding their first Content Marketing World Summit in November. The two-day meeting will be held in Cleveland, OH, and will focus on healthcare marketing, including professionals from the Mayo Clinic, Johns Hopkins Medicine and the Cleveland Clinic. Topics will include social media and content creation for hospitals, content marketing metrics and ROI and managing the content marketing process. It will be held November 7 to November 8.

The Crohn's and Colitis Foundation has named Lippincott Williams & Wilkins publisher of Inflammatory Bowel Disease. Lippincott is a division of Wolters Kluwer Health. The online journal is currently available to 12,000 institutions through Wolters Kluwer's research platform OvidSP.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.